| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045001738 |
| P356 | DOI | 10.1186/1475-2875-11-381 |
| P932 | PMC publication ID | 3519548 |
| P698 | PubMed publication ID | 23171202 |
| P5875 | ResearchGate publication ID | 233744593 |
| P50 | author | Brian D. Foy | Q37366383 |
| P2093 | author name string | Kevin C Kobylinski | |
| Jason H Richardson | |||
| P2860 | cites work | Malaria Management: Past, Present, and Future | Q21032466 |
| Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether | Q24792020 | ||
| Principles of activation and permeation in an anion-selective Cys-loop receptor | Q27667848 | ||
| Human malaria parasites in continuous culture | Q28131626 | ||
| Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus | Q71611314 | ||
| Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both gamma-aminobutyric acid-gated Rdl and glutamate-gated GluCl alpha chloride channel subunits | Q43992726 | ||
| Kinetics and efficiency of Plasmodium falciparum development in the midguts of Anopheles gambiae, An. funestus and An. nili. | Q44138873 | ||
| Effect of Plasmodium falciparum on blood feeding behavior of naturally infected Anopheles mosquitoes in western Kenya | Q44142284 | ||
| Why is the effect of malaria parasites on mosquito survival still unresolved? | Q44148052 | ||
| PROGNOSIS FOR INTERRUPTION OF MALARIA TRANSMISSION THROUGH ASSESSMENT OF THE MOSQUITO'S VECTORIAL CAPACITY. | Q44156698 | ||
| Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 | ||
| Immunodetection of Plasmodium falciparum zygotes and ookinetes in Anopheles blood meals | Q44169669 | ||
| Malaria parasites enhance blood-feeding of their naturally infected vector Anopheles punctulatus | Q44173551 | ||
| Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus | Q46438232 | ||
| Lack of in vitro effect of ivermectin on Plasmodium falciparum. | Q47985220 | ||
| The malaria parasite, Plasmodium falciparum, increases the frequency of multiple feeding of its mosquito vector, Anopheles gambiae. | Q55067560 | ||
| [A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg | Q69351880 | ||
| Plasmodium falciparum: modifications of the in vitro culture conditions improving parasitic yields | Q71463917 | ||
| Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans | Q28239336 | ||
| Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency | Q28316803 | ||
| The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism | Q28364254 | ||
| Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate | Q28469316 | ||
| Avermectins in arthropod vector management - prospects and pitfalls | Q30967839 | ||
| The genetics of ivermectin resistance in Caenorhabditis elegans | Q33893340 | ||
| Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs | Q33898575 | ||
| The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors | Q34126869 | ||
| Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | Q34177472 | ||
| Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug | Q34246661 | ||
| Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin | Q34388555 | ||
| Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors | Q34468442 | ||
| Endectocides for malaria control | Q35228261 | ||
| Mass drug treatment for lymphatic filariasis and onchocerciasis | Q35569083 | ||
| Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. | Q35582101 | ||
| Comparative evaluation of systemic drugs for their effects against Anopheles gambiae | Q35609560 | ||
| Insecticide treated nets: impact on vector populations and relevance of initial intensity of transmission and pyrethroid resistance. | Q35760899 | ||
| Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus | Q35893162 | ||
| Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease | Q36289280 | ||
| Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials | Q36800842 | ||
| Plasmodium-Mosquito Interactions: A Tale of Roadblocks and Detours | Q36882568 | ||
| Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria | Q37121012 | ||
| Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control | Q38936557 | ||
| The potential of ivermectin to control the malaria vector Anopheles farauti | Q39007292 | ||
| Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. | Q39012777 | ||
| A global index representing the stability of malaria transmission. | Q39139490 | ||
| Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages | Q39142724 | ||
| Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. | Q39511728 | ||
| Plasmodium: parasite chitinase and its role in malaria transmission | Q40624855 | ||
| Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival | Q40632950 | ||
| A scanning electron microscopic study of the sporogonic development of Plasmodium falciparum in Anopheles stephensi | Q42453009 | ||
| Effect of ivermectin on the ovarian development of Aedes aegypti (Diptera: Culicidae). | Q42986855 | ||
| Increased intradermal probing time in sporozoite-infected mosquitoes. | Q43032711 | ||
| Population dynamics of Plasmodium falciparum sporogony in laboratory-infected Anopheles gambiae | Q43536585 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Anopheles gambiae | Q135237 |
| Plasmodium falciparum | Q311383 | ||
| ivermectin | Q415178 | ||
| sporogony | Q61082809 | ||
| P304 | page(s) | 381 | |
| P577 | publication date | 2012-11-21 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae | |
| P478 | volume | 11 |
| Q92869595 | A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool |
| Q59789849 | A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria |
| Q36364245 | Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria |
| Q35809268 | Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals |
| Q59350625 | Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus |
| Q35664074 | Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae |
| Q98286185 | Comparison of the efficacy of Teatree oil with other current pharmacological management in human demodicosis |
| Q33933344 | Controlling malaria using livestock-based interventions: a one health approach |
| Q37464114 | Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya |
| Q64117418 | Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial |
| Q42414575 | Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda |
| Q34484629 | Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments |
| Q37278727 | Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector |
| Q92977368 | Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize |
| Q33579115 | Gates Grand Challenges Explorations award: Endectocides for Controlling Transmission of Mosquito-borne Diseases |
| Q62738094 | Human Direct Skin Feeding versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial) |
| Q50331630 | In vitro activity of ivermectin against Staphylococcus aureus clinical isolates |
| Q40432477 | Inhibition of Plasmodium Liver Infection by Ivermectin |
| Q92170025 | Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro |
| Q92709400 | Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study |
| Q39498838 | Ivermectin exhibits potent anti-mitotic activity |
| Q33882905 | Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles |
| Q44170175 | Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi |
| Q33593852 | Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety |
| Q33593846 | Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway |
| Q36858823 | Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination |
| Q33771668 | Ivermectin-treated cattle reduces blood digestion, egg production and survival of a free-living population of Anopheles arabiensis under semi-field condition in south-eastern Tanzania |
| Q40411509 | Ivermectin: a complimentary weapon against the spread of malaria? |
| Q47548444 | Microbial Pre-exposure and Vectorial Competence of Anopheles Mosquitoes |
| Q27901942 | Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals |
| Q56342028 | Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-prolongation (IVERMAL) |
| Q27972966 | Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. |
| Q50000887 | Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi |
| Q34281491 | Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control |
| Q59792487 | Reshaping the vector control strategy for malaria elimination in Ethiopia in the context of current evidence and new tools: opportunities and challenges |
| Q48218312 | Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. |
| Q35163829 | Screening for an ivermectin slow-release formulation suitable for malaria vector control |
| Q47161724 | What does not kill it makes it weaker: effects of sub-lethal concentrations of ivermectin on the locomotor activity of Anopheles aquasalis. |
Search more.